Citations 1
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s Disease
Friedenberg, Keith, Younes, Ziad , Seidler, Ursula , Bhandari, Bal Raj, Wang, Ke , Wendt, Emily, McKevitt, Matt, Zhao, Sally, Sundy, John S., Lee, Scott D. , Loftus, Edward V. , Loftus, Edward V , Schreiber, Stefan , Siegel, Corey A
Journal of Crohn's and Colitis | May 28, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available
